Lixte Biotech Hlds (LIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 2,599 | N/A | N/A | N/A |
| Receivables | 14 | N/A | N/A | N/A |
| Other current assets | 59 | 0 | 0 | 0 |
| TOTAL | $2,672 | $N/A | $N/A | $N/A |
| Non-Current Assets | ||||
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $2,672 | $N/A | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 144 | 0 | 0 | 0 |
| Other current liabilities | 94 | N/A | N/A | N/A |
| TOTAL | $238 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | ||||
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $238 | $N/A | $N/A | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 1 | N/A | N/A | N/A |
| Retained earnings | -27,089 | N/A | N/A | N/A |
| Other shareholders' equity | 3,500 | 0 | 0 | 0 |
| TOTAL | $2,434 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $2,672 | $0 | $0 | $0 |